Efficacy of upadacitinib and dupilumab on achieving stringent and composite skin and itch outcomes: an indirect comparison of adults with moderate-to-severe atopic dermatitis

被引：0

作者：

Armstrong, April W. ^{[1
]}

Hong, H. Chih-Ho ^{[2
,3
]}

Calimlim, Brian M. ^{[4
]}

Buessing, Marric G. ^{[5
]}

Crowell, Marjorie M. ^{[5
]}

Silverberg, Jonathan, I ^{[6
]}

机构：

[1] Univ Calif Los Angeles, Div Dermatol, Los Angeles, CA USA

[2] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada

[3] Prob Med Res, Surrey, BC, Canada

[4] AbbVie Inc, N Chicago, IL USA

[5] Medicus Econ LLC, Boston, MA USA

[6] George Washington Univ, Sch Med & Hlth Sci, Dept Dermatol, Washington, DC USA

来源：

关键词：

atopic dermatitis; moderate-to-severe; targeted therapies; comparative efficacy;

D O I：

10.1093/bjd/ljad498.029

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

524

引用

页码：II26 / II27

页数：2